These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for haematological rescue after high-dose consolidation chemotherapy. Van Hoef ME; Baumann I; Lange C; Luft T; de Wynter EA; Ranson M; Morgenstern GR; Yvers A; Dexter TM; Testa NG Ann Oncol; 1994 Mar; 5(3):217-24. PubMed ID: 7514434 [TBL] [Abstract][Full Text] [Related]
28. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493 [TBL] [Abstract][Full Text] [Related]
29. Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells. Vogel W; Kunert C; Blumenstengel K; Fricke HJ; Kath R; Sayer HG; Höffken K J Cancer Res Clin Oncol; 1998; 124(6):341-5. PubMed ID: 9692843 [TBL] [Abstract][Full Text] [Related]
30. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827 [TBL] [Abstract][Full Text] [Related]
32. In vivo mobilization of karyotypically normal peripheral blood progenitor cells in high-risk MDS, secondary or therapy-related acute myelogenous leukaemia. Carella AM; Dejana A; Lerma E; Podestà M; Benvenuto F; Chimirri F; Parodi C; Sessarego M; Prencipe E; Frassoni F Br J Haematol; 1996 Oct; 95(1):127-30. PubMed ID: 8857949 [TBL] [Abstract][Full Text] [Related]
33. Collection, analysis and transplantation of Ph-negative blood precursor cells in chronic myeloid leukemia. Frassoni F; Carella AM Leukemia; 1996 Jun; 10 Suppl 2():s30-2. PubMed ID: 8649050 [TBL] [Abstract][Full Text] [Related]
34. Combined chemotherapy and granulocyte colony-stimulating factor (G-CSF) mobilise large numbers of peripheral blood progenitor cells in pretreated patients. Lickliter JD; Begley CG; Boyd AW; Szer J; Grigg AP Leuk Lymphoma; 1994 Sep; 15(1-2):91-7. PubMed ID: 7532059 [TBL] [Abstract][Full Text] [Related]
35. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia. Boqué C; Petit J; Sarrá J; Cancelas JA; Muñoz J; Español JI; de la Banda E; Aventin A; Berlanga J; Ferrá C; Amill B; Torrico C; Azqueta C; Llucià M; García J; Grañena A Bone Marrow Transplant; 1996 Nov; 18(5):879-84. PubMed ID: 8932840 [TBL] [Abstract][Full Text] [Related]
36. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Demirer T; Buckner CD; Appelbaum FR; Petersen FB; Rowley S; Weaver CH; Lilleby K; Sanders J; Chauncey T; Storb R Bone Marrow Transplant; 1995 Jun; 15(6):915-22. PubMed ID: 7581091 [TBL] [Abstract][Full Text] [Related]
37. Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product. Dreger P; Marquardt P; Haferlach T; Jacobs S; Mülverstedt T; Eckstein V; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N Br J Cancer; 1993 Nov; 68(5):950-7. PubMed ID: 7692921 [TBL] [Abstract][Full Text] [Related]
38. Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen. Balduzzi A; Perseghin P; Dassi M; Bonanomi S; Rovelli A; Gaipa G; Biondi A; Uderzo C Bone Marrow Transplant; 2002 Oct; 30(7):413-6. PubMed ID: 12368951 [TBL] [Abstract][Full Text] [Related]
39. Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia. Corsetti MT; Lerma E; Dejana A; Basta P; Ferrara R; Benvenuto F; Vassallo F; Abate M; Piaggio G; Parodi C; Sessarego M; Li Pira G; Manca F; Carella AM Leukemia; 1999 Jul; 13(7):999-1008. PubMed ID: 10400414 [TBL] [Abstract][Full Text] [Related]
40. Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological control. Hughes TP; Grigg A; Szer J; Ho J; Ma D; Dale BM; Green RM; Norman JE; Sage RE; Herrmann R; Cannell P; Schwarer AP; Taylor K; Atkinson K; Arthur C Br J Haematol; 1997 Mar; 96(3):635-40. PubMed ID: 9054675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]